Elicio Therapeutics Stock (NASDAQ: ELTX) stock price, news, charts, stock research, profile.
Open | $9.150 |
Close | $8.990 |
Volume / Avg. | 37.127K / 58.867K |
Day Range | 8.820 - 9.150 |
52 Wk Range | 2.960 - 24.390 |
Market Cap | $102.210M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 56 |
Short Interest | - |
Days to Cover | 1 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Elicio Therapeutics (NASDAQ: ELTX) through any online brokerage.
Other companies in Elicio Therapeutics’s space includes: Anixa Biosciences (NASDAQ:ANIX), Cellectar Biosciences (NASDAQ:CLRB), Curis (NASDAQ:CRIS), Burning Rock Biotech (NASDAQ:BNR) and Armata Pharmaceuticals (AMEX:ARMP).
The latest price target for Elicio Therapeutics (NASDAQ: ELTX) was reported by Oppenheimer on Monday, April 1, 2024. The analyst firm set a price target for 0.00 expecting ELTX to fall to within 12 months (a possible -100.00% downside). 3 analyst firms have reported ratings in the last year.
The stock price for Elicio Therapeutics (NASDAQ: ELTX) is $10 last updated April 12, 2024 at 5:36 PM EDT.
There are no upcoming dividends for Elicio Therapeutics.
Elicio Therapeutics’s Q1 earnings are confirmed for Wednesday, May 15, 2024.
There is no upcoming split for Elicio Therapeutics.
Elicio Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.